Pokaż uproszczony rekord

Aetiology, prophylaxis and management of preeclampsia

dc.contributor.authorGronkowska, Karolina
dc.date.accessioned2021-09-30T17:13:10Z
dc.date.available2021-09-30T17:13:10Z
dc.date.issued2021-09-29
dc.identifier.issn1730-2366
dc.identifier.urihttp://hdl.handle.net/11089/39300
dc.description.abstractAlthough preeclampsia affects approximately 3%–8% of pregnancies worldwide and is a major contributor to maternal and neonatal mortality and morbidity, the aetiology of preeclampsia is still not fully understood. This review presents the current knowledge on the aetiology of preeclampsia, with a special emphasis on risk factors and their role, and describes recommendations for the prevention and treatment of preeclampsia.en
dc.language.isoen
dc.publisherWydawnictwo Uniwersytetu Łódzkiegopl
dc.relation.ispartofseriesActa Universitatis Lodziensis. Folia Biologica et Oecologicaen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.subjectproteinuriaen
dc.subjectgestational hypertensionen
dc.subjecttrophoblast invasionen
dc.subjectuteroplacental malperfusionen
dc.subjectendothelial dysfunctionen
dc.titleAetiology, prophylaxis and management of preeclampsiaen
dc.typeArticle
dc.page.number111-121
dc.contributor.authorAffiliationUniversity of Lodz, Faculty of Biology and Environmental Protection, Department of General Biophysics, Pomorska 141/143, 90-236 Lodz, Polanden
dc.identifier.eissn2083-8484
dc.referencesAlcala, M., Gutierrez-Vag, S., Castor, E., Guzman-Gutiérrez, E., Ramos-Álvarez, M., Vian, M. 2018. Antioxidants and oxidative stress: focus in obese pregnancies. Frontiers in Physiology, 9: 1569.en
dc.referencesAmaral, L.M., Wallace, K., Owens, M., LaMarca, B. 2017. Pathophysiology and Current clinical management of preeclampsia. Current Hypertension Reports, 19(8): 61.en
dc.referencesAouache, R., Biquard, L., Vaiman, D., Miralles, F. 2018. Oxidative stress in preeclampsia and placental diseases. International Journal of Molecular Sciences, 19(5): 1496.en
dc.referencesBenschop, L., Duvekot, J.J., Roeters van Lennep, J.E. 2019. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart, 105(16): 1273–1278.en
dc.referencesBraunthal, S., Brateanu, A. 2019. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Medicine, 7: 2050312119843700.en
dc.referencesBrown, M.A., Magee, L.A., Kenny, L.C., Karumanchi, S.A., McCarthy, F.P., Saito, S., Hall, D.R., Warren, C.E., Adoyi, G., Ishaku, S. 2018. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension, 72(1): 24–43.en
dc.referencesCornelius, D.C. 2018. Preeclampsia: from inflammation to immunoregulation. Clinical Medicine Insights: Blood Disorders, 11: 1179545X17752325en
dc.referencesCunningham, M.W.Jr., Vaka, V.R., McMaster K., Ibrahim, T., Cornelius D.C., Amaral L., Campbell N., Wallukat, G., McDuffy, S., Usry, N., Dechend, R., LaMarca, B. 2019. Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy. Pregnancy Hypertension, 15: 72–77.en
dc.referencesFox, R., Kitt, J., Leeson, P., Aye, C.Y.L., Lewandowski, A.J. 2019. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. Journal of Clinical Medicine, 8(10): 1625.en
dc.referencesGeldenhuys, J., Rossouw, T.M., Lombaard, H.A., Ehlers, M.M., Kock, M.M. 2018. Disruption in the regulation of immune responses in the placental subtype of preeclampsia. Frontiers in Immunology, 9: 1659.en
dc.referencesGobert, M. and Lafaille, J.J. 2012. Maternal-fetal immune tolerance, block by block. Cell, 150(1): 7–9.en
dc.referencesGodo, S., Shimokawa, H. 2017. Endothelial Functions. Arteriosclerosis, Thrombosis, and Vascular Biology, 37(9): e108–e114.en
dc.referencesJabrane-Ferrat, N., Siewiera, J. 2014. The up side of decidual natural killer cells: new developments in immunology of pregnancy. Immunology, 141(4): 490–497.en
dc.referencesKenny, L.C., Kell, D.B. 2017. Immunological tolerance, pregnancy, and preeclampsia: the roles of semen microbes and the father. Frontiers in Medicine, 4: 239.en
dc.referencesKim, J.-Y., Kim, Y.M. 2015. Acute atherosis of the uterine spiral arteries: clinicopathologic implycations. Journal of Pathology and Translational Medicine, 49(6): 462–471.en
dc.referencesLam, M.T.C., Dierking, E. 2017. Intensive Care Unit issues in eclampsia and HELLP syndrome. International Journal of Critical Illness and Injury Science, 7(3): 136–141.en
dc.referencesLi, J., LaMarca, B., Reckelhoff, J.F. 2012. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. American Journal of Physiology Heart and Circulatory Physiology, 303(1): H1–H8.en
dc.referencesLi, Y., Yan, J., Chang, H.-M., Chen, Z.-J., Leung, C.K. 2021. Roles of TGF-β superfamily proteins in extravillous trophoblast invasion. Trends in Endocrinology and Metabolism, 32(3): 170–189.en
dc.referencesLu, H.-Q., Hu, R. 2019. The role of immunity in the pathogenesis and development of pre-eclampsia. Scandinavian Journal of Immunology, 90(5): e12756.en
dc.referencesManna, S., McCarthy, C., McCarthy, F.P. 2019. Placental ageing in adverse pregnancy outcomes: telomere shortening, cell senescence, and mitochondrial dysfunction. Oxidative Medicine and Cellular Longevity, 2019: 3095383.en
dc.referencesMannaerts, D., Faes, E., Cos, P., Briedé, J.J., Gyselaers, W., Cornette, J., Gorbanev, Y., Bogaerts, A., Spaanderman, M., Craenenbroeck, E., Jacquemyn, Y. 2018. Oxidative stress in healthy pregnancy and preeclampsia is linked to chronic inflammation, iron status and vascular function. PloS One, 13(9): e0202919.en
dc.referencesMayrink, J., Costa, M.L., Cecatti, J.G. 2018. Preeclampsia in 2018: revisiting concepts, physiopathology, and prediction. The Scientific World Journal, 2018: 6268276.en
dc.referencesStaff, A.C. 2019. The two-stage placental model of preeclampsia: an update. Journal of Reproductive Immunology, 134–135: 1–10.en
dc.referencesTaravati, A., Tohidi, F. 2018. Comprehensive analysis of oxidative stress markers and antioxidants status in preeclampsia. Taiwanese Journal of Obstetrics & Gynecology, 57(6): 779–790.en
dc.referencesTomimatsu, T., Mimura, K., Matsuzaki, S., Endo, M., Kumasawa, K., Kimura, T. 2019. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. International Journal of Molecular Sciences, 20(17): 4246.en
dc.referencesTong, W., Giussani, D.A. 2019. Preeclampsia link to gestational hypoxia. Journal of Developmental Origins of Health and Disease, 10(3): 322–333.en
dc.referencesTurbeville, H.R., Sasser, J.M. 2020. Preeclampsia beyond pregnancy: long-term consequences for mother and child. American Journal of Physiology-Renal Physiology, 318(6): F1315–F1326.en
dc.contributor.authorEmailkarolina.gronkowska@unilodz.eu
dc.identifier.doi10.18778/1730-2366.16.22
dc.relation.volume17


Pliki tej pozycji

Thumbnail
Nazwa:
10835-Article_Text-27761-1-10- ...
Rozmiar:
533.0KB
Format:
PDF
Oglądaj/Otwórz

Pozycja umieszczona jest w następujących kolekcjach

Pokaż uproszczony rekord

https://creativecommons.org/licenses/by-nc-nd/4.0
Poza zaznaczonymi wyjątkami, licencja tej pozycji opisana jest jako https://creativecommons.org/licenses/by-nc-nd/4.0